Cue Biopharma, Inc.
CUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $22 | $49 | $52 | $64 |
| Short-Term Investments | $1 | $0 | $25 | $0 |
| Receivables | $1 | $2 | $0 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $25 | $51 | $77 | $68 |
| Property Plant & Equip (Net) | $5 | $7 | $11 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $2 | $3 | $3 | $3 |
| Total NC Assets | $7 | $10 | $14 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $32 | $62 | $91 | $83 |
| Liabilities | – | – | – | – |
| Payables | $3 | $4 | $3 | $3 |
| Short-Term Debt | $8 | $7 | $5 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $2 | $0 | $1 |
| Other Curr. Liab. | $3 | $4 | $4 | $3 |
| Total Curr. Liab. | $14 | $17 | $12 | $13 |
| LT Debt | $1 | $7 | $14 | $5 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $1 | $7 | $14 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $5 | $7 | $9 | $10 |
| Total Liabilities | $15 | $24 | $26 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$342 | -$301 | -$250 | -$197 |
| AOCI | $0 | $0 | -$0 | $0 |
| Other Equity | $359 | $338 | $316 | $263 |
| Total Equity | $17 | $37 | $66 | $65 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $32 | $62 | $91 | $83 |
| Net Debt | -$14 | -$34 | -$32 | -$52 |